🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
The primary objective of this study is to assess the suitability of the aut...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-20
Trial ID
NCT02124798
Treatments Being Tested
This study is an open-label, randomized, 2 parallel group, single dose stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-12-26
Trial ID
NCT01516450
Treatments Being Tested
GlaxoSmithKline (GSK) have submitted a Biologic License Application (BLA) f...
Status
No Longer Available
Location
GSK Investigational Site
Start Date
TBD
Trial ID
NCT03125486
Treatments Being Tested
Mechanistic study to assess whether dual B-cell immunotherapy by co-adminis...
Status
Unknown
Location
Addenbrooke's Hospital
Start Date
2019-02-01
Trial ID
NCT03967925
Treatments Being Tested
The objective of this study is to collect and assess the information about ...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-01-15
Trial ID
NCT03370263
Treatments Being Tested
This will be a randomized, parallel-group, open-label, single-dose study of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-14
Trial ID
NCT01894360
Treatments Being Tested
This is an open-label, randomized, parallel group, single dose study in hea...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-28
Trial ID
NCT04136145
Treatments Being Tested
Recent data indicate that Telitacicept is beneficial for lupus nephritis. O...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-08-25
Trial ID
NCT07077486
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-16
Trial ID
NCT01484496
Treatments Being Tested